TAMs (thymidine analogue mutations)
NAMs (nucleoside-associated resistance mutations)

Resistance Mutations in Patients Maintained on Failing Therapy  1/12/07

Selection of HIV Reverse Transcriptase (RT) Thymidine Analogue Mutations (TAMS) Rather than K65R is the Preferred Route of Resistance Seen in Patients with Virologic Failure on Once-Daily (QD) Trizivir (TZV) and Tenofovir (TDF). R Elion and others. - 12/18/05

Report on the XIV International HIV Drug Resistance Workshop: Parts 1-3 - 7/06/05

Differences in Enhanced Susceptibilities to NNRTIs and to Zidovudine in Site-directed Mutants (SDMs) Bearing K65R, L74V or M184V - 6/15/05

Resistance Mutations Before and After Tenofovir Regimen Failure - 5/25/05

Patterns of Drug Resistance Emerging from Patients Undergoing Intensification Therapy with Tenofovir - 10/20/04

Predictors of Selection of K65R Mutation: Tenofovir Use and Lack of Thymidine Analogue Mutations - 10/18/04

Experimental NRTI MIV-310 Efficiently Reduces HIV Viral Load in Patients Failing Multiple Drug Therapy: Results from a 4-week Phase II Study - 9/20/04

The Ideal Nucleoside/Nucleotide Backbone - 9/01/04

Review of HIV Drug Resistance Issues from the 15th International AIDS Conference in Bangkok - 8/06/04

Incidence of Reverse Transcriptase Genotypic Mutations in Children Treated with Dual NRTIs - 7/19/04

Nucleoside / Nucleotide Analogues in Clinical Use - 6/04/04